Nirmatrelvir+ritonavir/ruxolitinib interactionTumour lysis syndrome following drug interaction and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1980卷 / 1期

关键词：

D O I：

10.1007/s40278-023-48509-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：317 / 317

相关论文

共 50 条

[1] Nirmatrelvir+ritonavir/tacrolimusPancreatitis following drug interaction and off-label use: case report
Reactions Weekly, 2023, 1959 (1) : 505 - 505
[2] Nirmatrelvir+ritonavir/tacrolimus interactionVarious toxicities following drug interaction, drug toxicity and off-label use: case report
Reactions Weekly, 2023, 1958 (1) : 412 - 412
[3] Nirmatrelvir+ritonavir/tacrolimus interactionVarious toxicities following drug interaction, drug toxicity and off-label use: case report
Reactions Weekly, 2023, 1968 (1) : 241 - 241
[4] Buspirone/clonazepam/nirmatrelvir+ritonavir interactionEncephalopathy and off-label use: case report
Reactions Weekly, 2023, 1969 (1) : 98 - 98
[5] Nirmatrelvir+ritonavir/tacrolimus interactionTacrolimus toxicity following off label use and interaction: case report
Reactions Weekly, 2023, 1954 (1) : 373 - 373
[6] Nirmatrelvir/Ritonavir/TacrolimusAcute kidney injury following off-label use and drug interaction
Reactions Weekly, 2024, 2002 (1) : 380 - 380
[7] Nirmatrelvir+ritonavir/verapamil interactionVarious toxicities and off label use: case report
Reactions Weekly, 2023, 1943 (1) : 545 - 545
[8] Nirmatrelvir+ritonavir/venlafaxine interactionHyponatraemia following drug interaction: case report
Reactions Weekly, 2023, 1943 (1) : 544 - 544
[9] Nirmatrelvir+ritonavir/tozinameranVaccine failure, rebound COVID-19 and off-label use: case report
Reactions Weekly, 2022, 1933 (1) : 349 - 349
[10] Bebtelovimab/nirmatrelvir+ritonavir/remdesivirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1966 (1) : 90 - 90

← 1 2 3 4 5 →